Table 2.
Target | Sequences | Clinical Correlates in AD | Ref. |
---|---|---|---|
Blood–brain barrier (BBB) | Dynamic susceptibility contrast-enhanced MRI (DSC-MRI) | Degeneration of the BBB has been demonstrated in the hippocampus with the ageing process; however, that has been seen to appear earlier in subjects with MCI when compared with cognitively intact subjects | [91] |
Dynamic contrast-enhanced MRI (DCE-MRI) | Significantly higher BBB leakage rate in AD compared to controls in the grey matter; the leakage volume was significantly higher in the grey matter, in the normal-appearing white matter, and in the cortex | [95] | |
Brain atrophy | Three-dimensional (3D) T1-weighted magnetisation-prepared rapid acquisition gradient-echo (T1-MPRAGE) sequence | Structural brain changes are accurately consistent with Braak stages of neurofibrillary tangle deposition and neuropsychological deficits. Rates of change in several structural measures, including whole-brain, entorhinal cortex, hippocampus, and temporal lobe volumes, correlate closely with changes in cognitive performance, validating atrophy in these regions as markers of AD. | [98,99,100,101,102,103,104] |